)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Molecular Partners
Molecular Partners (MOLN) investor relations material
Molecular Partners Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary12 May, 2026
Company overview and financial position
Clinical-stage biotech focused on DARPin therapeutics, with operations in Switzerland and the US, and $100M in cash as of March 31, 2026.
Proprietary platforms enable innovation in targeted cancer therapies, leveraging partnerships with global experts.
Pipeline includes radio-DARPins and next-gen immune cell engagers, with early clinical readouts targeting high unmet needs.
DARPin technology and innovation
DARPin therapeutics offer high tumor selectivity, low immunogenicity, and deep tumor penetration due to small size.
Radio-DARPins act as isotope-agnostic vectors, enabling precise delivery of potent radioisotopes for solid tumors.
Flexibility in chelator and isotope selection allows parallel evaluation of 212Pb and 225Ac for optimal therapeutic effect.
Clinical pipeline and development progress
MP0712 (DLL3-targeted) in Phase 1/2a for SCLC and neuroendocrine cancers, with strong tumor uptake and favorable biodistribution in early human imaging.
MP0726 (MSLN-targeted) advancing to first-in-human imaging for ovarian cancer, maintaining binding despite shed MSLN.
Additional programs include next-gen immune cell engagers and switch-DARPins, with multiple candidates in preclinical and clinical stages.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Molecular Partners
- Expanded radiotherapeutics pipeline, reduced expenses, and strong cash runway through 2028.MOLN
Q4 202512 Mar 2026 - MP0712, a DLL3-targeted DARPin radiopharmaceutical, enters first-in-human trials in 2025.MOLNTD Cowen 2nd Annual Radiopharmaceutical Innovation Summit3 Feb 2026
- MP0712 showed robust tumor targeting and safety, supporting ongoing Phase 1/2a clinical trials.MOLNStudy update2 Feb 2026
- Cash runway into 2027 and pipeline advances set up key clinical milestones in 2025.MOLNH1 202423 Jan 2026
- DARPin-based cancer therapies advance with key clinical milestones and strong financial backing.MOLN44th Annual J.P. Morgan Healthcare Conference15 Jan 2026
- Key clinical milestones in radiotherapy and immune cell engagers expected in 2024–2025.MOLN43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
- Radio-DARPin and immuno-oncology pipeline advance, cash runway extends into 2027.MOLNH2 202429 Dec 2025
- Imminent clinical trials and strong early data highlight a pivotal year for DARPin-based therapies.MOLNTD Cowen 45th Annual Healthcare Conference26 Dec 2025
- Biopharma seeks up to $300M via flexible securities offering to advance DARPin pipeline and growth.MOLNRegistration Filing16 Dec 2025
Next Molecular Partners earnings date
Q1 202620 May, 2026
Molecular Partners
Next Molecular Partners earnings date
Q1 202620 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage